Apoptosis enhancing nuclease (AEN) (NM_022767) Human Untagged Clone

CAT#: SC324654

AEN (untagged)-Human apoptosis enhancing nuclease (AEN)



  "NM_022767" in other vectors (5)

CNY 2,400.00

CNY 6,270.00


货期*
现货

规格
    • 10 ug

Product images

经常一起买 (4)
Rabbit polyclonal antibody to Apoptosis-enhancing nuclease (apoptosis enhancing nuclease)
    • 100 ul

CNY 6,281.00


TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Synonyms ISG20L1; pp12744
Vector pCMV6-AC
E. coli Selection Ampicillin (100 ug/mL)
Mammalian Cell Selection Neomycin
Sequence Data
>OriGene sequence for NM_022767.2 CCGGAAGAGACACGCGGGGCTTCAGGCTGCTGCCCCATTGGAAGATTACTCCCCAGGCTT
CCCTTGCCCCAAGCAGTGAGCTGACTGGAATGGTACCCCGGGAGGCCCCTGAGTCTGCTC
AGTGCCTGTGCCCTTCCCTCACCATCCCAAATGCCAAGGATGTGCTTCGGAAGAGGCACA
AGAGAAGGAGCCGACAGCACCAGCGGTTCATGGCCCGGAAGGCCTTGCTGCAGGAGCAGG
GGCTGCTGAGCATGCCTCCAGAACCAGGGTCCTCCCCACTGCCCACCCCTTTCGGGGCAG
CGACAGCAACTGAAGCTGCCAGCAGTGGGAAGCAGTGTCTGAGGGCTGGATCTGGCAGTG
CCCCATGCAGCAGAAGGCCTGCTCCCGGGAAAGCCTCAGGGCCCTTGCCCAGCAAGTGTG
TGGCTATCGACTGTGAGATGGTGGGCACGGGACCCCGAGGGCGGGTAAGCGAGCTGGCCC
GCTGTTCCATTGTGAGCTACCATGGCGATGTCCTCTATGACAAGTACATCAGGCCTGAGA
TGCCCATCGCTGACTACCGTACCCGCTGGAGTGGCATCACTCGGCAGCACATGCGCAAGG
CTGTCCCCTTCCAGGTGGCCCAGAAAGAGATCCTTAAGCTCCTGAAGGGCAAGGTGGTGG
TGGGGCACGCGCTGCACAACGACTTCCAGGCGCTCAAGTATGTCCACCCTCGGAGCCAGA
CCCGGGATACCACCTATGTCCCAAACTTCCTCAGCGAGCCCGGCCTCCACACCCGGGCCC
GGGTCTCTCTAAAGGACCTGGCCCTGCAGCTGCTGCACAAGAAGATCCAGGTGGGCCAGC
ACGGGCACTCATCAGTAGAAGATGCCACGACAGCCATGGAGCTCTACCGGCTGGTGGAGG
TGCAGTGGGAACAGCAGGAGGCCCGCAGCCTCTGGACCTGCCCCGAGGACAGAGAACCTG
ACAGCAGCACAGACATGGAACAGTACATGGAGGACCAGTACTGGCCCGATGACCTGGCCC
ACGGCAGCAGAGGAGGAGCCAGGGAGGCACAGGACAGAAGGAATTGAGAAGGGGGCGGGG
CTCCCTGGCTGGGCTTCCGGTGTGGCCGGTAGGAAGTGGGGGCCAGGAGAGCAGCGGGCA
CTCCTTCCTGGGCAGGGTGGGGCAGGATGCAGTGAGCCAGCCCCAGGGCCAGAGGAGTTG
GGGTCATCTGTTACCTTGACACCCTCTGCACACAGCATAGCCCTCTCTCTCTCCAGGGCT
GTTGGTTCTTTCTCCTGACTCCTGTGGTTTTGCTAATGGCACTTTACAGACTCCATGGAG
ATGTCAGGTGGACCATCTTCTAGGGCCCAGCAGGAGTAGGGAATGTGCCAACAGACTGCC
CAGGTTGCCGTGGCCTTCCCCACCCCCCAGATCTCCTGAGTCATCATGCTGTGCTAATGA
AAGGGATCATATCATCCTCTCTGGGGATGGTGGGTGGGGGTGTCAATATCCTGGAGCTCC
CTTACCCCAACTCAATGACTTGGGGGTAAAGTTCTCTTCCTTTTGTTGCCTACCTCTTCC
TCCACTCATTTGGGTTCAGAATAAACATGCCCTGAAGTTAAAGGGGAGTTAAGTCCTAAA
GGAGGCATTTCTTCCCCACCTCCCTGACCTGGAACTCTGGCTACAGCCATTGTAGGAACT
CCGTGCCTGGCCTGTCAGCTCCCTGCTAGGCTACAGTGGAATAGCAGAGCCCACAGGCTT
CTCGTGGGGAGTTGGCTCCTTAACATTTCTTGGCAACAGAAAGCCCCAGGCACAGCTCAG
GGAGGAGGGAAGGCAGGTAAGCTTTGGACGAGAACTGGCATATTTATTTTGACCCAAATC
AGGGATTTCCCCAGTCCACCCAGTACTGGGCTCTTAAGCAAAAGTCTGAGAAACAAGACA
GTGGTTTGAATTCTGGGGCCTTTGTGTAGGATTGTGCCTGACCTTTATTTATTTATTAAC
AGCAGGGCCACTCGTCTAGGGCAGTGGAGTCTGCGTGTCTCCTGGGGCTGGGGCAGGGCA
TTGGCAGTTACGCAGTGGCCCTGAACCTGGTCTGGTGCCCCCGAACCTGGTCTGATGCCC
CCTCAGCTCTTTGACAATCACTGTGGCTGTTGGGTTTTCTCCTATTTCTAAAAATGTTCT
CTTCTTTCCTAAGTGACAGTTTTGAAGTATTGGATAACCAAGAGCTCAGGTCACACAGAC
CTTGGAGCCCCATCTTTGCTTGCAGCTTAGCTTTGAGATACTAAGCAAGCGAGGGACTTC
ACTCTTGAGCCTGTTTTTTCCTCATCTGTAAAGTGGGGATAGTGGTACGGCCTACCTCAT
AGGGTTGTAATGAGCACTAAATGTGAAGTGCTTGGCACAGTGCCTGGCACATGGTGAGCC
ACAGCTACTGTGAGTTTCTGTTTATCCCCCTTTTTTTTTTTTTAAGCCCATTGTTTATTC
TTTGAGAATTTGTTGTAACTTCTTCAGGATAACACCTGAGTCCACAGGCTGAGCAGCTGT
GGCCCAGACAGAACTGCTCCGGCTTGGCTGTTCCAGCAGGTGGGGCGCTGGCCTCGGTGA
GGGCACAGCAGCAAGGTTCACGGATATCCGTGTGTCTTGTCTGTGGCCACCAGGCACAGG
TTTGGCTTCCGGTCAGTGTCCCGACACTGTGCGGGAGGTGACAACAGAGCAAAGCAGCGC
AGGGGTCAGGGAGGTGGAGACACTGCTGAAATCACACTACCCCACCCTCAGCTGAAGCCC
CACGTTCCACAAACTTGGGGTCATAGATTGTCCAGTCACTGGCTCCCTCCCTGTCAGCAC
AGCACAGAGGAAGGGGCTAACTGAATCTTTTACCACTTCTGGCCTGGCTCCAGAACTTTG
TTCTAGATTCCTTAAAAGTCGGTAGCTGATGTCAAACTCAATTGAGCAGTAGCTTTGATC
CCTTGGTCTGGGGGTCGAAGGAAGATGGCGCTGTTATCAGCGGGGAAATGTACTATTTAA
GATCAGCTTTGTTGTAAAACCATTTGTTCTAGAATAAAACTCAATTGGAAACGTGAAAAA
AAAAAAAAAAAAAA
Restriction Sites Please inquire     
ACCN NM_022767
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
OTI Annotation This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_022767.2, NP_073604.2
RefSeq Size 3074 bp
RefSeq ORF 978 bp
Locus ID 64782
UniProt ID Q8WTP8
Domains EXOIII
Gene Summary Exonuclease with activity against single- and double-stranded DNA and RNA. Mediates p53-induced apoptosis. When induced by p53 following DNA damage, digests double-stranded DNA to form single-stranded DNA and amplifies DNA damage signals, leading to enhancement of apoptosis.[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

其它Apoptosis enhancing nuclease产品

Customer Reviews 
Loading...